'Clinical triad' findings in pediatric Klippel-Feil patients

published_or_final_versio

The safety and efficacy of mesenchymal stem cells for prevention or regeneration of intervertebral disc degeneration: a systematic review

General Posters: abstract no. GP86INTRODUCTION: Mesenchymal stem cells (MSCs) have been used to halt the progression or regenerate the disc with hopes to prevent or treat discogenic back pain. However, the safety and efficacy of the use of MSCs for such treatment in animal and human models at short and long term assessment (i.e. greater than 48 weeks) have not been systematically addressed. This study addressed a systematic review of comparative controlled studies addressing the use of MSCs to that of no treatment/saline for the treatment of disc degeneration. METHODS: Online databases were extensively searched. Controlled trials in animal models and humans were eligible for inclusion. Trial design, MSC characteristics, injection method, disc assessment, outcome intervals, and complication events were assessed. Validity of each study was assessed addressing trial design. Two individuals independently addressed the aforementioned. RESULTS: Twenty-two animal studies were included. No human comparative controlled trials were reported. All three types of MSCs (i.e. derived from bone marrow, synovial and adipose tissue) showed successful inhibition of disc degeneration progression. From three included studies, bone marrow derived MSC showed superior quality of disc repair when compared to other treatments, including TGF-β1, NP bilaminar co-culture and axial distraction regimen. However, osteophyte development was reported in two studies as potential complication of MSC transplantation. CONCLUSIONS: Based on animal models, the current evidence suggests that in the short-term MSC transplantation is safe and effective in halting disc degeneration; however, additional and larger studies are needed to assess the long-term regenerative effects and potential complications. Inconsistency in methodological design and outcome parameters prevent any robust conclusions. In addition, randomized controlled trials in humans are needed to assess the safety and efficacy of such therapy.published_or_final_versio

'Clinical Triad' findings in Klippel-feil patients

E-Poster - Congenital Deformity: no. 530It has been propagated that Klippel-Feil Syndrome (KFS) is associated with the clinical triad findings (CTF) of short neck, low posterior hairline, and limited range of motion. This study noted that CTFs are not consistently noted in KFS patients. KFS patients with extensive congenitally fused cervical segments were more likely to exhibit one of the components of CTF.postprin

Stark shift and parity non-conservation for near-degenerate states of xenon

We identify a pair of near-degenerate states of opposite parity in atomic Xe, the $5p^5 10s \,\, ^2[3/2]_2^o$ at $\rm{E}=94759.927$ cm$^{-1}$ and $5p^5 6f \,\, ^2[5/2]_2$ at $\rm{E}= 94759.935$ cm$^{-1}$, for which parity- and time-odd effects are expected to be enhanced by the small energy separation. We present theoretical calculations which indicate narrow widths for both states and we report a calculated value for the weak matrix element, arising from configuration mixing, of $|W|=2.1$ Hz for $^{132}$Xe. In addition, we measured the Stark effect of the $5p^5\,6f$ $^2[5/2]_{2}$ and $5p^5 \,6f \ ^2[3/2]_2$ ($\rm{E} =94737.121\,\rm{cm}^{-1}$) states. The Stark-shift of the $6f$ states is observed to be negative, revealing the presence of nearby $6g$ states at higher energies, which have not been observed before. The Stark-shift measurements imply an upper limit on the weak matrix element of $|W|\!<\!5$ Hz for the near-degenerate states ($10s \,\, ^2[3/2]_2^o$ and $6f \,\, ^2[5/2]_2$), which is in agreement with the presented calculations.Comment: 11 pages, 6 figure

Inpatient and outpatient loop electrosurgery excision procedure for cervical intraepithelial neoplasia: a retrospective analysis

Purpose: To determine whether the outpatient loop electrosurgical excision procedure (LEEP) conization (out-LEEP) is as effective and safe as inpatient LEEP conization (in-LEEP) with regard to the complete removal of cervical dysplasia, recurrence-free survival and post-operative morbidity. Methods: 233 patients were included in this retrospective cohort study from January 2002 to December 2007. 181 had outpatient treatment and 52 inpatient treatment. We used Mann-Whitney U test, two-sided Fisher's exact test, Chi-square test, log rank test and Kaplan-Meier curve. Results: Incomplete excision was found in 16/52 (30.8%) cases in the inpatient group and 46/181 (25.4%) in the outpatient group (P=0.48). Six patients had post-operative complications: two cases of secondary haemorrhage in each group (in-LEEP 3.8%, out-LEEP 1.1%, P=0.22) and two cases of cervical stenosis amongst inpatients (3.8%, P=0.049). Alteration of specimen by thermal artifact were reported in 4/52 (7.7%) of in-LEEP cones and 10/181 (5.5%) of out-LEEP cones (P=0.52). Measurements of cones in both groups were comparable with a mean depth of 9.35mm (±5.5mm) and 8.4mm (±3.4mm), respectively. Conclusion: Our results suggest that efficacy and safety of ambulatory LEEP conization is comparable as in inpatient procedur

Serum metabolomic biomarkers and lumbar disc degeneration

Oral Presentations: no. O-16INTRODUCTION: It has been suggested that altered metabolism may contribute to lumbar disc degeneration (DD). Quantitative high-throughput serum nuclear magnetic resonance (NMR) metabolomics has recently been introduced as a cost-effective way to obtain comprehensive data on systemic metabolism. Here we report our preliminary work on the identification of serum metabolomic biomarkers in relation to lumbar DD, with a primary focus on small molecules and ...postprin

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

Micropapillary carcinoma ( MPC ) is a rare histological special type of breast cancer, characterized by an aggressive clinical behaviour and a pattern of copy number aberrations ( CNAs ) distinct from that of grade‐ and oestrogen receptor ( ER )‐matched invasive carcinomas of no special type ( IC‐NSTs ). The aims of this study were to determine whether MPCs are underpinned by a recurrent fusion gene(s) or mutations in 273 genes recurrently mutated in breast cancer. Sixteen MPCs were subjected to microarray‐based comparative genomic hybridization ( aCGH ) analysis and Sequenom OncoCarta mutation analysis. Eight and five MPCs were subjected to targeted capture and RNA sequencing, respectively. aCGH analysis confirmed our previous observations about the repertoire of CNAs of MPCs . Sequencing analysis revealed a spectrum of mutations similar to those of luminal B IC‐NSTs , and recurrent mutations affecting mitogen‐activated protein kinase family genes and NBPF10 . RNA ‐sequencing analysis identified 17 high‐confidence fusion genes, eight of which were validated and two of which were in‐frame. No recurrent fusions were identified in an independent series of MPCs and IC‐NSTs . Forced expression of in‐frame fusion genes ( SLC2A1–FAF1 and BCAS4–AURKA ) resulted in increased viability of breast cancer cells. In addition, genomic disruption of CDK12 caused by out‐of‐frame rearrangements was found in one MPC and in 13% of HER2 ‐positive breast cancers, identified through a re‐analysis of publicly available massively parallel sequencing data. In vitro analyses revealed that CDK12 gene disruption results in sensitivity to PARP inhibition, and forced expression of wild‐type CDK12 in a CDK12 ‐null cell line model resulted in relative resistance to PARP inhibition. Our findings demonstrate that MPCs are neither defined by highly recurrent mutations in the 273 genes tested, nor underpinned by a recurrent fusion gene. Although seemingly private genetic events, some of the fusion transcripts found in MPCs may play a role in maintenance of a malignant phenotype and potentially offer therapeutic opportunities. © 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106752/1/path4325.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/106752/2/path4325-sup-0001-AppendixS1.pd

Is lumbar facet joint tropism developmental or secondary to degeneration? An international, large-scale multicenter study by the AOSpine Asia Pacific Research Collaboration Consortium

published_or_final_versio

Fabrication of ZnS-Bi-TiO 2 Composites and Investigation of Their Sunlight Photocatalytic Performance

The ZnS-Bi-TiO 2 composites were prepared by the sol-gel method and were characterized by X-ray photoelectron spectroscopy (XPS), transmission electron microscopy (TEM), X-ray diffraction (XRD) and UV-visible diffuse reflectance spectroscopy (UV-Vis DRS). It is found that the doped Bi as Bi 4+ /Bi 3+ species existed in composites, and the introducing of ZnS enhanced further the light absorption ability of TiO 2 in visible region and reduced the recombination of photogenerated electrons and holes. As compared to pure TiO 2 , the ZnS-Bi-TiO 2 exhibited enhanced photodegradation efficiency under xenon lamp irradiation, and the kinetic constant of methyl orange removal with ZnS-Bi-Ti-0.005 (0.0141 min −1 ) was 3.9 times greater than that of pure TiO 2 (0.0029 min −1 ), which could be attributed to the existence of Bi 4+ /Bi 3+ species, the ZnS/TiO 2 heterostructure